Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 162

    1.

    Genetic heterogeneity in Loa loa parasites from southern Cameroon: A preliminary study.

    Higazi TB, Klion AD, Boussinesq M, Unnasch TR.

    Filaria J. 2004 Jun 29;3(1):4.PMID: 15225348 [PubMed - as supplied by publisher]Related articlesFree article

    2.

    Report of a Scientific Working Group on Serious Adverse Events following Mectizan(R) treatment of onchocerciasis in Loa loa endemic areas.

    Scientific Working Group on Serious Adverse Events in Loa Loa endemic areas.

    Filaria J. 2003 Oct 24;2 Suppl 1:S2.PMID: 14975059 [PubMed - as supplied by publisher]Related articlesFree article

    3.

    Co-infection with Onchocerca volvulus and Loa loa microfilariae in central Cameroon: are these two species interacting?

    Pion SD, Clarke P, Filipe JA, Kamgno J, Gardon J, Basáñez MG, Boussinesq M.

    Parasitology. 2006 Jun;132(Pt 6):843-54. Epub 2006 Feb 10.PMID: 16469200 [PubMed - indexed for MEDLINE]Related articles

    4.

    Satellite mapping of Loa loa prevalence in relation to ivermectin use in west and central Africa.

    Thomson MC, Obsomer V, Dunne M, Connor SJ, Molyneux DH.

    Lancet. 2000 Sep 23;356(9235):1077-8. Erratum in: Lancet 2000 Sep 30;356(9236):1198. PMID: 11009145 [PubMed - indexed for MEDLINE]Related articles

    5.

    Epidemiology of concomitant infections due to Loa loa, Mansonella perstans, and Onchocerca volvulus in rain forest villages of Cameroon.

    Wanji S, Tendongfor N, Esum M, Ndindeng S, Enyong P.

    Med Microbiol Immunol. 2003 Feb;192(1):15-21. Epub 2003 Jan 24.PMID: 12592559 [PubMed - indexed for MEDLINE]Related articles

    6.

    Microfilarial distribution of Loa loa in the human host: population dynamics and epidemiological implications.

    Pion SD, Filipe JA, Kamgno J, Gardon J, Basáñez MG, Boussinesq M.

    Parasitology. 2006 Jul;133(Pt 1):101-9.PMID: 16764737 [PubMed - indexed for MEDLINE]Related articles

    7.

    Combined Utilisation of Rapid Assessment Procedures for Loiasis (RAPLOA) and Onchocerciasis (REA) in Rain forest Villages of Cameroon.

    Wanji S, Tendongfor N, Esum M, Yundze SS, Taylor MJ, Enyong P.

    Filaria J. 2005 Apr 7;4(1):2.PMID: 15817124 [PubMed - as supplied by publisher]Related articlesFree article

    8.

    [Analysis of the prevention of post-ivermectin Loa loa encephalopathy by administration of initial low dose]

    Kamgno J, Gardon J, Boussinesq M.

    Med Trop (Mars). 2000;60(3):275-7. French. PMID: 11258063 [PubMed - indexed for MEDLINE]Related articles

    10.

    Prevalences of Loa loa microfilaraemia throughout the area endemic for the infection.

    Boussinesq M, Gardon J.

    Ann Trop Med Parasitol. 1997 Sep;91(6):573-89. Review.PMID: 9425360 [PubMed - indexed for MEDLINE]Related articles

    11.

    Structure of the microfilarial reservoir of Loa loa in the human host and its implications for monitoring the progr,ammes of Community-Directed Treatment with Ivermectin carried out in Africa.

    Pion DS, Gardon J, Kamgno J, Gardon-Wendel N, Chippaux JP, Boussinesq M.

    Parasitology. 2004 Nov;129(Pt 5):613-26.PMID: 15552406 [PubMed - indexed for MEDLINE]Related articles

    12.

    Homologs of the Brugia malayi diagnostic antigen BmR1 are present in other filarial parasites but induce different humoral immune responses.

    Noordin R, Aziz RA, Ravindran B.

    Filaria J. 2004 Dec 31;3(1):10.PMID: 15627400 [PubMed - as supplied by publisher]Related articlesFree article

    13.

    Serious adverse events following treatment with ivermectin for onchocerciasis control: a review of reported cases.

    Twum-Danso NA.

    Filaria J. 2003 Oct 24;2 Suppl 1:S3.PMID: 14975060 [PubMed - as supplied by publisher]Related articlesFree article

    14.

    Variation in incidence of serious adverse events after onchocerciasis treatment with ivermectin in areas of Cameroon co-endemic for loiasis.

    Twum-Danso NA, Meredith SE.

    Trop Med Int Health. 2003 Sep;8(9):820-31.PMID: 12950668 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Mapping the distribution of Loa loa in Cameroon in support of the African Programme for Onchocerciasis Control.

    Thomson MC, Obsomer V, Kamgno J, Gardon J, Wanji S, Takougang I, Enyong P, Remme JH, Molyneux DH, Boussinesq M.

    Filaria J. 2004 Aug 6;3(1):7.PMID: 15298709 [PubMed - as supplied by publisher]Related articlesFree article

    16.

    [Ivermectin]

    Boussinesq M.

    Med Trop (Mars). 2005;65(1):69-79. Review. French. PMID: 15903082 [PubMed - indexed for MEDLINE]Related articles

    17.

    Control of onchocerciasis.

    Boatin BA, Richards FO Jr.

    Adv Parasitol. 2006;61:349-94. Review.PMID: 16735169 [PubMed - indexed for MEDLINE]Related articles

    18.

    Clinical picture, epidemiology and outcome of Loa-associated serious adverse events related to mass ivermectin treatment of onchocerciasis in Cameroon.

    Boussinesq M, Gardon J, Gardon-Wendel N, Chippaux JP.

    Filaria J. 2003 Oct 24;2 Suppl 1:S4.PMID: 14975061 [PubMed - as supplied by publisher]Related articlesFree article

    19.

    A Framework for Decision-Making for Mass Distribution of Mectizan(R) in Areas Endemic for Loa loa.

    Addiss DG, Rheingans R, Twum-Danso NA, Richards FO.

    Filaria J. 2003 Oct 24;2 Suppl 1:S9.PMID: 14975066 [PubMed - as supplied by publisher]Related articlesFree article

    20.

    Programmatic and Communication Issues in Relation to Serious Adverse Events Following Ivermectin Treatment in areas Co-endemic for Onchocerciasis and Loiasis.

    Haselow NJ, Akame J, Evini C, Akongo S.

    Filaria J. 2003 Oct 24;2 Suppl 1:S10.PMID: 14975067 [PubMed - as supplied by publisher]Related articlesFree article